Notice: Undefined offset: 1 in /var/www/tmr/wp-content/plugins/accelerated-mobile-pages/includes/vendor/amp/includes/utils/class-amp-image-dimension-extractor.php on line 244
Insulet Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PODD - The Malaysian Reserve
Categories: PR Newswire

Insulet Corporation Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – PODD

LOS ANGELES, July 15, 2026 /PRNewswire/ — The DJS Law Group reminds investors of a class action lawsuit against Insulet Corporation (“Insulet” or “the Company”) (NASDAQ: PODD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholders who purchased shares of PODD during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD: February 21, 2025 to May 26, 2026

DEADLINE: August 31, 2026

CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Insulet failed to maintain appropriate controls over its manufacturing processes. The Company’s manufacturing problems created safety risks for its customers. Based on these facts, Insulet’s public statements were false and materially misleading throughout the class period.

If you are a shareholder who suffered a loss, contact us to participate.

WHY DJS LAW GROUP? DJS Law Group’s primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.

Join the case to recover your losses.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

David J. Schwartz

DJS Law Group

274 White Plains Road, Suite 1

Eastchester, NY 10709

Phone: 914-206-9742

Email: David@djslawllp.com

View original content:https://www.prnewswire.com/news-releases/insulet-corporation-sued-for-securities-law-violations—contact-the-djs-law-group-to-discuss-your-rights–podd-302825931.html

SOURCE DJS Law Group LLP

Share
Published by

    Notice: Trying to get property of non-object in /var/www/tmr/wp-content/plugins/nextgen-gallery/products/photocrati_nextgen/modules/third_party_compat/module.third_party_compat.php on line 473

    Notice: Trying to get property of non-object in /var/www/tmr/wp-content/plugins/nextgen-gallery/products/photocrati_nextgen/modules/third_party_compat/module.third_party_compat.php on line 473

Recent Posts

Harbour BioMed and Kelun-Biotech Announce NMPA Approval of IND Application for HBM7575/SKB575 for the Treatment of Asthma

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 15, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142),…

43 mins ago

Sanctuary Wealth’s Flexibility Drives Continued Growth With $5.9 Billion Expansion in First Half

Strong first half reflects continued wirehouse breakaway momentum and growing demand for Sanctuary's expanded affiliation…

44 mins ago

Retirement Confidence Holds Steady Despite Nearly Half of Non-Retirees Doubting They’ll Fully Retire, Thrivent Survey Finds

Nearly three in five non-retirees say they're confident they'll have enough money to retire from…

44 mins ago

CEO Confidence Slips in Q2 2026 as Inflation and Economic Uncertainty Take Hold

Vistage Small and Midsize Business CEO Survey Reveals Growth Expectations Remain Stable Despite Pessimism About…

44 mins ago

Propel to report Q2 2026 financial results

TORONTO, July 15, 2026 /CNW/ - Propel Holdings Inc. ("Propel") (TSX: PRL), the fintech facilitating…

44 mins ago

HERVolution Therapeutics Presents Clinical Evidence of HERV-K Driving Metabolic Senescence at the International Congress on Obesity 2026

Findings demonstrate HERV-K is required for senescence-associated inflammation in metabolically challenged cells and is reactivated…

44 mins ago